USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
      Featured
      Our Next Event
      Register for LSI Asia ‘26
      500+ Investors & Strategics
      See LSI Asia '26 Attendee List
      Events Overview
      • See Who's Attending
      • Who Attends
      • Why Present
      Upcoming Summits
      • LSI Asia ‘26
      • LSI Europe '26
      • LSI USA ‘27
      Past Summits
      • LSI Asia ‘25
      • LSI Europe ‘25
      • LSI USA ‘26
      • Archives
  • Insights
      Featured
      Just Launched
      Compass AI
      New Report
      Emerging Innovators Report
      Compass Al
      Emerging Innovators Report
      Market Data
      Custom Research
  • Magazine
      Featured
      March Edition
      Explore Latest Editions
      The Lens Magazine
      Start Your Subscription
      Magazine
      • The Lens Magazine
      • Explore the Newest Edition
      • Read Free Articles
  • Resources
      Featured
      Released Weekly
      The LSI Alumni Weekly Recap
      Just Released
      2025 LSI Alumni Funding Report
      Resources
      • Research Desk
      • Testimonials
      • Video Library
      • Photo Gallery
  • Company
      Featured
      Our Next Event
      Register for LSI Asia '26
      Just Launched
      Compass AI
      Company
      • About Us
      • Our Team
      • Press
  • Contact Us
Contact Us
USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
  • Insights
  • Magazine
  • Resources
  • Company
Events Overview
  • See Who's Attending
  • Who Attends
  • Why Present
Upcoming Summits
  • LSI Asia ‘26
  • LSI Europe ‘26
  • LSI USA ‘27
Past Summits
  • LSI Asia ‘25
  • LSI Europe ‘25
  • LSI USA ‘26
  • Archives
Featured
Our Next Event
Register for LSI Asia '26
350+ Investors & Strategics
See LSI Asia '26 Attendee List
Compass Al
Emerging Innovators Report
Market Data
Custom Research
Featured
Just Launched
Compass AI
New Report
Emerging Innovators Report
Magazine
The Lens Magazine
Explore the Newest Edition
Read Free Articles
Featured
March Edition
Explore Latest Editions
The Lens Magazine
Start Your Subscription
Resources
Research Desk
Testimonials
Video Library
Photo Gallery
Featured
Released Weekly
The LSI Alumni Weekly Recap
Just Released
2025 LSI Alumni Funding Report
Company
About Us
Our Team
Press
Featured
Our Next Event
Register for LSI Asia '26
Just Launched
Compass AI
Join our Next Event
LSI Asia ‘26, June 30 - July 2, 2026
Shangri-La, Singapore
Register Today
Compass AI
Navigate medtech with AI
insights and data you can trust
Demo Compass AI
The Lens Magazine
The Lens Medtech
Magazine is LSI's most
curated industry coverage.
  1. Video Library
  2. Leadership in the Workplace | Panel w/ Leslie Trigg, Nadine Hachach-Haram & Amy Belt Raimundo

Leadership in the Workplace | Panel w/ Leslie Trigg, Nadine Hachach-Haram & Amy Belt Raimundo

Medtech continuously develops some of the best leaders in any industry. The combination of putting patients first by saving and extending lives, while leading world class teams who produce some of the most innovative technology platforms requires agile, thoughtful and courageous leadership.
Share social-facebook social-x social-linkedin
Speakers
Leslie Trigg
Leslie Trigg
CEO, Outset Medical
Bio Bio
Nadine Hachach-Haram
Nadine Hachach-Haram
Founder & CEO, Proximie
Bio Bio
Amy Belt Raimundo
Amy Belt Raimundo
Co-Founder & Managing Partner, Convey Capital
Bio Bio
Joe Mullings
Joe Mullings
Chairman & CEO, The Mullings Group Companies
Bio Bio
View Video Transcript
lsi logo
Contact Us

Upcoming Events

LSI ASIA ‘26
LSI ASIA ‘26
June 30 - July 2, 2026
Singapore
LSI EUROPE ‘26
LSI EUROPE ‘26
Sept 28 - Oct 1, 2026
Barcelona
LSI USA ‘27
LSI USA ‘27
March 15-19, 2027
Dana Point, CA

More From LSI

  • Attend an Event
  • Sponsor an Event
  • Compass, by LSI
  • The Lens, Magazine by LSI

Resources

  • Research Desk
  • Photo Gallery
  • Video Library
  • Testimonials
  • About Us

17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647

714-847-3540

© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy | Your Privacy Choices | Delete my Data

Request Info
close
STEP 1
close-icon
The Lens - Complimentary Issue
close
close

Subscription Includes

Request Info

Global Medtech Market Analysis & Projections (MAP), 2021-2031
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf report

The Global Medtech Market Analysis and Projections (MAP) provides global market forecasts (2021 – ’31), share-by-supplier data, and analyst insights on 23 major device markets (e.g., Cardiovascular, Orthopedics, Neurovascular, In-Vitro Diagnostics) and 200+ technology subsegments. Understand major market trends and projections across the medtech industry with what medtech strategics and consulting firms have referred to as their “gold standard” for device market sizing data.

Global Surgical Procedure Volumes Dashboard, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Global Surgical Procedure Volumes database is the single source of truth for understanding diagnostic and therapeutic procedure volumes on a global scale. With coverage on 37 countries, including the United States, Europe’s Big Five, China, India, Japan and more for 12 major procedure markets (Cardio, Ortho, General Surgery, Radiosurgery, Neuro, OB/GYN and more), this fully interactive database is designed to facilitate one-to-one analyses of procedures, countries, and regions. Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

United States Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United States Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United States. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Aesthetics, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Aesthetics Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Aesthetics Procedures Database covers major aesthetic procedures, including: Biopsies, Punch Biopsies, Shave Biopsies, Incisional Biopsies, Lesion Removal Procedures, Curettage, electrocautery, and electrocoagulation lesion destruction, Photodestruction, Cryotherapy-based lesion destruction, Lesion Removal Procedures: Traditional and Other, Abdominoplasty, Blepharoplasty, Breast Augmentation, Breast Lift, Breast Reduction, Buttock Augmentation, Buttock Lift, Cheek Implants, Chin Augmentation, Facelift, Forehead Lift, Gynecomastia Treatment, Hair Transplantation, Lip Augmentation, Liposuction, Lower Body Lift, Otoplasty, Rhinoplasty, Thigh Lift, Upper Arm Lift, Vaginal Rejuvenation, Surgeries for Cleft Palate and Lip, Surgeries for Burn Injuries.

Cardio, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Cardiothoracic and Interventional Cardiology Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Cardiothoracic and Interventional Cardiology Procedures Database covers major cardiothoracic and interventional cardiology procedures, including: CABG Surgeries Off-Pump CABG, On-Pump CABG, Valve Procedures Aortic Valve Replacements, Mitral Valve Replacements, MV Repairs, AV Repairs, PV Replacements, PV Repairs, TV Operations, Percutaneous Valvuloplasties, Percutaneous Valve Replacements, CHD Surgeries Ventricular Septal Defect Closures, Patent Ductus Arteriosus Repairs, Atrial Septal Defect Closures, Repair of Tetralogy of Fallot, Arterial Shunts Surgeries, Atrioventricular Septal Defect Repairs, Transposition of Great Artery Procedures, Anomalous Pulmonary Venous Return Repairs, Other Congenital Heart Disease Surgeries, Other Cardiothoracic Surgeries Aortic Aneurysm Procedures, Other Cardiothoracic Surgeries, Diagnostic and Therapeutic Catheterizations, Stand-Alone Diagnostic Cardiac Catheterizations, Percutaneous Coronary Interventions, Coronary Interventions Radial Approach, Coronary Interventions Femoral Approach, Heart Rhythm Procedures Conventional Pacemaker Procedures, ICD Procedures, Cardiac Resynchronization Device Procedures, Combined Defib/Resynch Device Procedures, Cardiac Ablations.

ENT, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ear, Nose, and Throat Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ear, Nose, and Throat Surgical Procedures Database covers major ear, nose, and throat procedures, including: Tonsillectomies, Operations on the Ear, FESS, Tracheostomies, Thyroidectomies & Parathyroidectomies, Stand-Alone Adenoidectomies, Tongue Operations, Laryngeal Operations, Pharyngeal Operations, Radical Neck Dissection.

General, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The General Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The General Surgeries Procedures Database covers major general surgical procedures, including: Cholecystectomies Laparoscopic Cholecystectomies, Open Cholecystectomies, Appendectomies, Laparoscopic Appendectomies, Open Appendectomies, Herniorrhaphies Laparoscopic Herniorrhaphies, Open Herniorrhaphies, Bariatric Surgeries Laparoscopic Bariatric, Open Bariatric, Selected Other Endoscopic General & Colorectal Procedures Esophageal (Other Endoscopic), Stomach & Intestinal (Other Endoscopic), Colorectal (Other Endoscopic), Liver (Other Endoscopic), Gallbladder & Biliary (Other Endoscopic), Pancreatic (Other Endoscopic), Other (Other Endoscopic), Other Surgeries Esophageal (Other General, non-Endoscopic), Stomach & Intestinal (Other General, non-Endoscopic), Colorectal (Other General, non-Endoscopic), Liver (Other General, non-Endoscopic), Gallbladder & Biliary (Other General, non-Endoscopic), Pancreatic (Other General, non-Endoscopic), Other (Other General, non-Endoscopic).

Neuro, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Neurosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Neurosurgery Procedures Database covers major neurosurgical procedures, including: Surgeries for Traumatic Brain Injuries, Ventricular & Shunt Surgeries, New Shunt Placements, Revision Shunt Surgeries, Endoscopic Third Ventriculostomies, Diagnostic Ventricular Endoscopies, Vascular Lesion Procedures, Vascular Lesion Surgeries, Vascular Lesion Coil Procedures, Pituitary Tumor Surgeries, Open Pituitary Tumor Surgeries, Endoscopic Pituitary Tumor Surgeries, Intracranial Tumor Surgeries, Open Intracranial Tumor Surgeries, Endoscopic Intracranial Tumor Surgeries, Cranioplasties, Intracranial Neurostimulation and Peripheral Nerve Procedures, Intracranial Neurostimulator Implant Procedures, Peripheral Nerve Neurostimulation Procedures, Other Peripheral Nerve Procedures.

OB/GYN, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Obstetric and Gynecological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Obstetric and Gynecological Surgical Procedures Database covers major obstetric and gynecological procedures, including: Obstetrical Surgeries Cesarean Sections, Destructive Operations, Episiotomies, Other Obstetrical Surgeries, Gynecological Surgeries Colposcopies, Hysterectomies, Salpingo-Oophorectomies & Oophorectomies, Colposcopies, Salpingo-Oophorectomies & Oophorectomies, Hysterectomies, Total Hysterectomies, Subtotal Hysterectomies, Vaginal Hysterectomies, Breast Cancer Surgeries, Breast Reconstruction Surgeries, Breast-Conserving Surgeries, and Mastectomies, among other surgeries.

Ophthalmology, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ophthalmological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ophthalmological Surgical Procedures Database covers major ophthalmological procedures, including: Cataract Surgeries, Phacoemulsification Surgeries, ICCE Surgeries, ECCE Surgeries, MSICS Surgeries, Refractive Surgeries.

Orthopedic, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Orthopedic Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Orthopedic Surgical Procedures Database covers major orthopedic procedures, including: Hip Arthroplasties Revision Hip Arthroplasties, Hip Resurfacing Procedures, Primary Hip Arthroplasties - Total Hip, Partial Hip, Knee Arthroplasties Revision Knee Arthroplasties, Primary Knee Arthroplasties - Partial Knee, Primary Knee Arthroplasties - Total Knee, Extremity Fractures Using Hardware Extremity Fractures Using Hardware - Upper Extremities, Extremity Fractures Using Hardware - Fractures of the Femoral Neck & Shaft, Extremity Fractures Using Hardware - Other Lower Extremity, Arthroscopies Knees (Arthroscopies), Shoulders (Arthroscopies), Ankles (Arthroscopies), Feet & Toes (Arthroscopies), Others (Arthroscopies), Other Joint Arthroplasties Finger & Hand, Wrist, Elbow, Shoulder, Ankle & Foot.

Peripheral Vascular, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Peripheral Vascular Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Peripheral Vascular Surgeries Procedures Database covers major peripheral vascular procedures, including: Arterial Procedures Thrombectomies & Thromboendarterectomies, Carotid Artery Thrombectomies, Upper Limb Artery Thrombectomies, Iliac Artery Thrombectomies, Renal Artery Thrombectomies, Lower Limb Artery Thrombectomies, Arterial Angioplasties, Carotid Artery Angioplasties, Upper Limb Artery Angioplasties, Iliac Artery Angioplasties, Renal Artery Angioplasties, Lower Limb Artery Angioplasties, Arterial Bypasses, Carotid Artery Bypasses, Upper Limb Artery Bypasses, Iliac Artery Bypasses, Renal Artery Bypasses, Aortofemoral and Aortobifemoral Bypasses, Femoropopliteal Bypasses, Femorotibeal Bypasses, Other Lower Limb Bypasses, Venous Procedures Head, Neck, & Upper Limb Thrombectomies & Thromboendarterectomies of Dialysis Access Venous Segments, Thrombectomies & Thromboendarectomies of Other Upper Limb Veins, Angioplasties of Dialysis Access Venous Segments, Angioplasties of Head, Neck and Other Upper Limb Veins, Lower Limb Venous Procedures Removals of the Saphenous Vein, Removals of Other Veins of the Lower Limbs.

Spine, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spine Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Spine Surgical Procedures Database covers major spine procedures, including: Cervical Spine Surgeries Cervical Spine Decompressions, Cervical Spine Discectomies, Cervical Spine Fusions, Cervical Spine Disc Replacements, Thoracic and Deformity Procedures Thoracic Spine Decompressions, Thoracic Spine Discectomies, Thoracic Spine Fusions, Instrumented Procedures for Deformities, Lumbar Procedures Lumbar Spine Decompressions, Lumbar Spine Discectomies, Lumbar Spine Fusions, Insertion of Lumbar Interspinous Process Spacer, Lumbar Spine Disc Replacements, Vertebroplasties & Kyphoplasties Vertebroplasties, Kyphoplasties, Other Spine Surgeries.

SRS, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Stereotactic Radiosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Stereotactic Radiosurgery Procedures Database covers major stereotactic radiosurgery procedures, including: Intracranial SRS Procedures, Extracranial SRS Procedures, Extracranial Spine Procedures, Extracranial Lung Procedures, Other Extracranial Procedures.

Urological, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Urological Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Urological Surgeries Procedures Database covers major urological procedures, including: Kidney Stone Procedures Extra Corporeal Shock Wave Lithotripsy, Percutaneous Nephro Lithotripsy, Ureteroscopies, Open Kidney Stone Procedures, BPH Procedures Transurethral Prostatectomies, Other BPH Surgeries, Prostatectomies, Nephrectomies Partial Nephrectomies, Radical Nephrectomies, Bladder Procedures Therapeutic Endoscopies, Diagnostic Endoscopies, Urethral Catheterizations of Bladder.

Global Markets for Hip Replacement Implants, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for hip replacement implants. The market for hip replacement implants includes all prosthetic devices used to replace damaged sections of the hip joint, including those used in total and semi/hemi replacement procedures. This market snapshot is intended to provide a high-level overview of the global market for hip replacement implants, with key insights into: Procedure volumes from 2022 to 2028, Market forecasts from 2022 to 2028, Competitive landscape analysis of major competitors, Insights into key market events for strategics and startups. Companies covered in this report include: B. Braun, DePuy Synthes, DJO Global, Exactech, Johnson & Johnson, Medacta, MicroPort Scientific, Ortho Development, OSSIS, SERF SAS, Smith+Nephew, Symbios Orthopedie, Total Joint Orthopedics, Zimmer Biomet.

Global Markets for Peripheral Vascular Guidewires, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Atherectomy Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Electrosurgery, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Vascular Balloons & Vena Cava Filter, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for percutaneous transluminal angioplasty (PTA) balloons and inferior vena cava (IVC) filters. A PTA balloon is used in the treatment of peripheral artery disease (PAD) to open a narrowed or blocked artery. IVC filters are permanent or temporary devices to prevent the travel of thrombotic material to the lungs. These devices are frequently used in the management of patients with severe PAD. This market snapshot is intended to provide a high-level overview of the global market for PTA balloons and IVC filters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Acotec Scientific, Adient Medical, B. Braun, BD, Biotronik, Boston Scientific, Brosmed, Cagent Vascular, Cardinal Health, CONMED, Cook Medical, Concept Medical, Cordis, Covellus, Degania Medical, iVascular, Medtronic, Merit Medical, NextStep Medical, Nipro, OrbusNeich, Orchestra BioMed, Philips, Terumo, TriReme Medical.

Global Markets for Mechanical Heart Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Tissue Heart Valve Replacement, 2023-2028
Published:
2023
Next Update:
Q2 2030
Deliverables:
excel pdf

Description coming soon.

Global Markets for Transcatheter Mitral Valve Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Femoral Closure, 2023-2029
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for femoral closure devices. Femoral closure devices are used to achieve hemostasis of the hole in the artery that is created to perform catheter-based cardiovascular or endovascular procedures. This market snapshot is intended to provide a high-level overview of the global market for femoral closure devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Cardinal Health, Cardiva, Cordis, CyndRx, Endocor, Haemonetics, Morris Innovative, Rex Medical, Teleflex, Terumo, Transluminal Technologies, Vasorum, Vivasure Medical.

Global Markets for Tricuspid Valve Repair, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for tricuspid valve repair devices. Tricuspid valve repair is the preferred surgical approach for the treatment of degenerative tricuspid valve disease. The market is currently experiencing a renaissance with the introduction and development of transcatheter solutions for tricuspid valve repair and replacement. Devices covered within the scope of this analysis include tricuspid valve annuloplasty rings and transcatheter tricuspid valve repair devices. This market snapshot is intended to provide a high-level overview of the global market for tricuspid valve repair devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, CroiValve, Edwards Lifesciences, Innoventric, Medtronic, Mitral Holdco, Mitralix, NaviGate, OrbusNeich, TriCares, Venus Medtech.

Global Markets for Percutaneous Pulmonary Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for transcatheter pulmonary valve devices. Pulmonary valve replacement is performed primarily for the treatment of pulmonary valve stenosis, a relatively rare disease associated with congenital heart defects. Devices covered within the scope of this analysis include transcatheter pulmonary valve implants for valve repair and replacement. This market snapshot is intended to provide a high-level overview of the global market for transcatheter pulmonary valve devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Edwards Lifesciences, Medtronic, PolyVascular, Venus Medtech.

Global Markets for Coronary Angio Guidewires & Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for coronary angiography catheters and guidewires. These devices are essential to perform coronary angiography, a minimally invasive medical procedure used to visualize blood flow, identify blockages and narrowing of the coronary arteries. Devices covered within the scope of this analysis include coronary angiography catheters and coronary angiography guidewires. This market snapshot is intended to provide a high-level overview of the global market for coronary angiography catheters and guidewires, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AngioDynamics, B. Braun, Boston Scientific, Cardinal Health, Cook Medical, Cordis, Medtronic, Merit Medical, Philips, Teleflex, Terumo.

Global Markets for Oncology Ablation Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology ablation catheters. These devices are used as a therapeutic modality employing energy to selectively destroy cancerous tissue. Devices covered within the scope of this analysis include radiofrequency and microwave ablation electrodes, excluding cryoablation devices, which are covered in a separate report. The snapshot offers a high-level overview of the global market for oncology ablation catheters and guidewires, with key insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: AngioDynamics, Baylis, Boston Scientific, Canyon Medical, CAPS Medical, EDAP, Galvanize Therapeutics, Imagin Medical, Medtronic, Mermaid, Mirai Medical, Monteris, Sonablate, Stryker, TROD Medical, and US Medical Innovations.

Global Markets for ENT Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for endoscopic devices for ear, nose, and throat (ENT) surgery. These devices are used to examine and operate on the structures and tissues in the ear, nose, and throat. Devices covered within the scope of this analysis include ENT endoscopic surgical instruments, balloon sinus and dilation catheters, and rigid endoscopes and bronchoscopes. This market snapshot is intended to provide a high-level overview of the global market for ENT endoscopic surgery devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: 3NT Medical, Acclarent, Conmed, Endoluxe, Entellus Medical, Intuitive Surgical, Johnson & Johnson, KARL STORZ, Medtronic, Olympus, Pentax, Pristine Surgical, Richard Wolf, Smith & Nephew, Stryker, Tympany Medical.

Global Markets for Cell Delivery Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cell delivery catheters. These devices are primarily research-use devices for the delivery of cellular therapies for the treatment of chronic diseases, such as cardiovascular disease and cancer. Devices covered within the scope of this analysis include cell delivery catheters. This market snapshot is intended to provide a high-level overview of the global market for cell delivery catheters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: BioCardia, Biosense Webster, Boston Scientific, Cordis, Medtronic, Mercator MedSystems, TriSalus Life Sciences, TRI Medical.

Global Markets for Urology Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for urology and renal devices, focusing on treatments for six major conditions: End-stage renal disease (ESRD), Incontinence, Calculi (stones), Benign prostatic hyperplasia (BPH), Prostatitis, and Erectile dysfunction (ED). The devices covered within this analysis encompass a range of tools for diagnosis, treatment, and management, including urinary bags, foley catheters, catheter insertion kits, intermittent catheters, endourology devices, BPH ablation devices, lithotripsy devices, and artificial penis devices. The snapshot provides key insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: 3M, Applied Medical, Astratech, Balton, Baxter Healthcare, B. Braun, BD, Boston Scientific, Calyxo, Corinth Medtech, Coloplast, EndoMed, Flume Catheter Company, Hollister, ICU Medical, Karl Storz, Medline, Medtronic, Merit Medical, Nipro, Olympus, SonoMotion, Teleflex, and Urovision.

Global Markets for External Pain Pumps, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for external pain pumps. These devices are used to provide patients with consistent, long-lasting pain relief by delivering pain medication epidurally, intravenously, or subcutaneously. Devices covered within the scope of this analysis include external infusion pumps for pain management. This market snapshot is intended to provide a high-level overview of the global market for external pain pumps, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Avanos, B. Braun, BioQ Pharma, Epic Health, ICU Medical, InfuTronix, Medical Flow Systems, Medipacs, MicroPort, Smiths Medical, Teleflex.

Global Markets for Ureteral Access Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence delves into the global market for ureteral access devices, crucial components utilized alongside ureteroscopy or percutaneous nephrolithotomy procedures. These devices facilitate dilation and create a working channel for various urologic interventions. The snapshot aims to offer insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it provides a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Amecath, Applied Medical, BD, Boston Scientific, Cook Medical, Envaste, Johnson & Johnson, Mednova, Olympus, Richard Wolf, Rocamed, Teleflex, and Terumo.

Global Markets for Pelvic Floor Repair, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for pelvic floor repair mesh. These products are used during surgical procedures to repair prolapse and urinary incontinence. Devices covered within the scope of this analysis include pelvic floor repair/reconstruction mesh. This market snapshot is intended to provide a high-level overview of the global market for pelvic floor repair mesh, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: BD, Boston Scientific, Coloplast, Cook Medical, Ethicon, Johnson & Johnson.

Global Markets for Atrial Fibrillation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Neurovascular Devices Ischemic, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence analyzes the global market for devices used in the treatment of ischemic stroke, focusing on solutions designed to remove occlusions in blood vessels to prevent and treat this condition. The market snapshot offers insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Cerenovus, Ceretrieve, Cordis, InNeuroCo, Julier, Medtronic, MicroPort Scientific, Microvention, Penumbra, Phenox, Poseydon Medical, Route 92 Medical, Stryker, and Terumo.

Global Markets for Neuromodulation Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global neuromodulation market – a thriving market for managing and treating neurological diseases, chronic pain, and other chronic conditions. Types of neuromodulation, or neurostimulation, devices include implantable and transcutaneous devices, including wearable devices. This market snapshot is intended to provide a high-level overview of the global neuromodulation market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bionics, Alyve Medical, Axonics, Biotronik, Boston Scientific, EBT Medical, electroCore Medical, Inspire Medical, LivaNova, Medtronic, Neuromod Devices, Nevro.

Global Markets for Vertebroplasty Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vertebral augmentation products, which are crucial in treating vertebral compression fractures, often caused by osteoporosis or spinal tumors. Vertebroplasty and kyphoplasty are the primary surgical interventions, and the market includes products such as vertebroplasty and kyphoplasty cement, as well as delivery devices. The snapshot aims to provide a comprehensive overview of the global vertebral augmentation products market, with key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Halma, IZI Medical, Medtronic, Mendec, Merit Medical, RevBio, and Stryker.

Global Markets for TAVI/TAVR, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Drug Delivery, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Benign Prostation Hyperplasia Implants, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hypertrophy/hyperplasia (BPH). These implants are reversible solutions for men suffering from lower urinary tract symptoms (LUTS) caused by prostate enlargement. This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Butterly Medical, Endotherapeutics, Olympus, ProArc, ProVerum, Teleflex, Urotronic, ZenFlow.

Global Markets for Cryoablation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for cryoablation devices for non-cardiovascular applications. These devices are used to freeze and induce cellular damage and death for indications including cancer, dermatological conditions, peripheral vascular disease, and urological conditions. This market snapshot is intended to provide a high-level overview of the global cryoablation devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Boston Scientific, Brymill Cryogenics, Channel Medsystems, CooperSurgical, CPSI Biotech, CryoConcepts, CryoProbe, CryoSurgery, CSA Medical, Endocare, Endocision, Grand Cryo, Ictero Medical, KryoLife, Mectronic Medical, Sedivention, Siemens Healthineers, Varian Medical Systems, Wallach Surgical.

Global Markets for Diagnostic Electrophysiology Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for diagnostic electrophysiology catheters. These devices are used to measure and map electrical activity within the heart to identify aberrant electrical activity that causes arrhythmias. LSI projects that this market will remain in a high growth phase due to improving technology for the surgical treatment of cardiac arrhythmias and atrial fibrillation (AF). This market snapshot is intended to provide a high-level overview of the global diagnostic electrophysiology catheters market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AccuPulse, Acutus Medical, BD, Biosense Webster, Boston Scientific, CardioNXT, CoreMap, Johnson & Johnson, Kardium, Medtronic, MicroPort Scientific, Stereotaxis.

Global Markets for Hernia Repair, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence (LSI) provides an analysis of the global market for hernia mesh products for the surgical repair of hernias. The global market for hernia mesh products is projected to see moderate growth throughout the forecast period covered by the analysis. While the market has been negatively impacted by ongoing lawsuits associated with product complications, the next generation of products has helped the market to recover for one of the most performed abdominal surgeries. This market snapshot is intended to provide a high-level overview of the global market for hernia mesh products, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Allergan, Ariste Medical, BD, Cook Medical, Deep Blue Medical Advances, Ethicon, Exogenesis, Integra Lifesciences, Johnson & Johnson, LifeCell, Medtronic, Novus Scientific, Tarian Medical, TELA Bio, TISSIUM, W.L. Gore.

Global Markets for CRM Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac rhythm management (CRM) devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT-Ds). These implantable devices are used to restore the natural rhythm and function of the heart that can be impaired as a result of cardiac rhythm disorders and heart failure. This market snapshot is intended to provide a high-level overview of the global CRM devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AtaCor Medical, BioTrace Medical, Biotronik, Boston Scientific, Cairdac, Electroducer, FineHeart, Lepu Medical, LivaNova, Medico, Medtronic, Merit Medical, Microport Scientific, Osypka Medical, Pacetronix.

Global Markets for Neurovascular Devices Hemorrhagic, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for neurovascular devices for the treatment of hemorrhagic stroke. These solutions are used to treat intracerebral bleeds, ruptured aneurysms, and other neurovascular deformities that lead to the pooling of blood vessels that have ruptured inside and outside of the brain. This market snapshot is intended to provide a high-level overview of the global market for neurovascular devices for hemorrhagic stroke, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Acandis, Artio Medical, Endostream Medical, Medtronic, MicroPort Scientific, Microvention, Phenox, Penumbra, Rapid Medical, Shape Memory Medical, Stryker, Terumo, Wallaby Medical.

Global Markets for Renal Denervation, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for renal denervation devices for the treatment of refractory hypertension (i.e., high blood pressure that does not respond to pharmaceuticals). The market for renal denervation devices includes radiofrequency and ultrasound catheters which are used to ablate the renal nerves. This market snapshot is intended to provide a high-level overview of the global market for renal denervation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Ablative Solutions, Brattea, Medtronic, Metavention, Otsuka Medical, ReCor Medical, SoniVie.

Global Markets for Upper+Lower Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence analyzes the global market for suture anchors used in upper and lower extremity repair and reconstruction procedures. Suture anchors play a critical role in securing soft tissue to bone, particularly for severe soft tissue tears. The market encompasses bioabsorbable, biocomposite, metallic, and PEEK suture anchors. The snapshot aims to offer insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Acumed, Acuitive Technologies, aevumed, Anika Therapeutics, Arthrex, ConMed, DePuy Synthes, Johnson & Johnson, Mitek, OSSIO, Paragon 28, Responsive Arthroscopy, Riverpoint Medical, Smith & Nephew, Stryker, and Zimmer Biomet.

Global Markets for Peripheral Stents, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for biliary and peripheral vascular stents. These devices are used to maintain and restore patency to anatomical ducts or vessels that have become obstructed due to the formation of plaque, narrowing of the natural lumen, or presence of benign and malignant growths. This market snapshot is intended to provide a high-level overview of the global peripheral vascular and biliary stents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, BD, Biotronik, Boston Scientific, Bryan Medical, Cardinal Health, Cook Medical, Cordis, Endo GI Medical, Hood Labs, Maquet, Medtronic, Merit Medical, MicroPort Scientific, Olympus, Q3 Medical, Zorion Medical.

Global Markets for Electromagnetic Navigation Systems, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for electromagnetic navigation systems for tracking, guiding, and positioning instruments during surgery. These systems provide surgeons and the surgical team with real-time information on the position and orientation of instruments used during open and minimally invasive surgeries. This market snapshot is intended to provide a high-level overview of the global electromagnetic navigation systems market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Brainlab, Collin Medical, Elucent Medical, Fiagon, Heal Force, Joimax, Karl Storz, Medtronic, Olympus, Stryker, Veran Medical Technologies.

Global Markets for GI Endoscopy, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot report from Life Science Intelligence provides an analysis of the global market for gastrointestinal (GI) endoscopic devices. These devices are used to visualize, diagnose, and surgically treat conditions of the GI tract. The market for GI endoscopic devices includes endoscopes and endoscopic instruments. This market snapshot is intended to provide a high-level overview of the global market for GI endoscopic devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Ambu, Applied Medical, Aqua Medical, Aspero Medical, B. Braun, Boston Scientific, ConMed, Endoluxe, Ethicon, Integra Lifesciences, Intuitive Surgical, IQ Endoscopes, Johnson & Johnson, Karl Storz, Medtronic, MiWendo Solutions, Olympus, Purple Surgical, Richard Wolf, Stryker, Teleflex.

Global Markets for Hemodialysis, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for hemodialysis solutions. Hemodialysis is an essential treatment for patients suffering from end-stage renal disease due to kidney failure. Hemodialysis systems, catheters, and dialyzers are components integral to hemodialysis treatment. This market snapshot is intended to provide a high-level overview of the global hemodialysis solutions market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Asahei Kasei, AngioDynamics, B. Braun, Baxter, Bellco, Byonyks, Diality, Fresenius, Hemoclean, Humacyte, Intermedt, Inspira Health, iRen-MEDICAL, Medivators, Merit Medical, NextKidney, Nikkiso, Nipro, Rockwell Medical, Telelfex, Terumo, Toray Medical, TVA Medical, Vantive.

Globals Markets for Cardiac Ablation, 2023-2028
Published:
Next Update:
Deliverables:

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac ablation devices, which are used for the treatment of arrhythmic heart conditions, such as atrial fibrillation. The market for cardiac ablations devices is projected to see strong growth throughout the forecast period covered by this analysis, driven by demographic trends and the adoption of new technologies for the treatment of new ablation technologies, such as Pulsed Field Ablation. Devices covered within the scope of this analysis include cardiac ablation catheters. This market snapshot is intended to provide a high-level overview of the global market for cardiac ablation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Adagio Medical, AtriAN Medical, AtriCure, Biosense Webster, Boston Scientific, Electrophysiology Frontiers, Field Medical, Galvanize Therapeutics, Healium Medical, Johnson & Johnson, Medtronic, Stereotaxis.

Global Markets for Atrial Septal Occlusion, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for atrial septal occlusion devices. These devices are used to close atrial septal defects (ASDs), an abnormal hole in the wall of the upper chambers of the heart that are present at birth. This market snapshot is intended to provide a high-level overview of the global ASD occlusion devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, atHeart Medical, Cardia, Hanyu Medical, Lifetech Scientific, Occlutech, W.L. Gore.

Global Markets for Aortic Grafts, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for aortic stent grafts for the treatment of aortic aneurysm. The market for aortic stent grafts includes open (surgical) and endovascular (transcatheter) aortic stent grafts used in the repair of abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). This market snapshot is intended to provide a high-level overview of the global market for aortic stent grafts, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Cook Medical, Endoron, Endospan, Lombard Medical, Medtronic, MicroPort Scientific, Taurus Vascular, Terumo, TripleMed, W.L. Gore.

Global Markets for Interventional Cardiology Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for interventional cardiology devices for the treatment of cardiovascular diseases such as heart failure or severe atherosclerosis. The market for interventional cardiology devices includes devices used to diagnose and treat diseases related to the coronary arteries. Devices included within the scope of this report include coronary stents, catheters, angioplasty balloons, guidewires, and intravascular ultrasound catheters. This market snapshot is intended to provide a high-level overview of the global market for interventional cardiology devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bifurcation Systems, B. Braun, BD, Boston Scientific, Cardinal Health, Cook Medical, Corflow Therapeutics, Fastwave Medical, Lemaitre Vascular, Medtronic, Merit Medical, MicroPort Scientific, NirvaMed, Philips, Teleflex, Terumo, Translumina.

Global Markets for Oncology Embolization, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization, and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death. This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: ABK Biomedical, Arsenal Medical, Boston Scientific, Cook, Cordis/Cardinal Health, Instylla, Medtronic, Merit Medical, Ned Medical, Obsidio, SirTex Medical, Stryker, Terumo, Varian.

Global Markets for Vascular Access Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vascular access devices, which are essential for continuous and long-term access to the bloodstream for administering intravenous drugs and fluids. The market encompasses various types of devices, including peripherally inserted central catheters (PICC), midline catheters, central venous catheters (CVC), and implantable ports. The snapshot aims to provide a comprehensive overview of the global market for vascular access devices, offering key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Access Vascular, AngioDynamics, B. Braun, Baxter, Becton, Dickinson & Company (BD), Bluegrass Vascular, C.R. Bard, Cook Medical, ICU Medical, Medline, Smiths Medical, Teleflex, Terumo, Vygon, and Yushin Medical.

Global Markets for Rotator Cuff Repair Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for rotator cuff repair suture anchors for the treatment of rotator cuff injuries. The market for rotator cuff repair suture anchors includes anchors composed of biocompatible polymers and metals. This market snapshot is intended to provide a high-level overview of the global market for rotator cuff repair suture anchors, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Aevumed, Arthrex, Atreon Orthopedics, ConMed, DePuy Synthes, Embody, Inovedis, Smith & Nephew, Stryker, Tetrous, Wright Medical, Zimmer Biomet.

Global Markets for Electrical Stimulation Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Wearable Monitoring Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Low Complexity Medical Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Canada Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Canada Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Canada. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Germany Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Germany Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Germany. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

France Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The France Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for France. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

U.K. Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United Kingdom Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United Kingdom. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Italy Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Italy Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Italy. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Spain Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spain Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Spain. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Poland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Poland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Poland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Netherlands Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Netherlands Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Netherlands. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Belgium Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Belgium Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Belgium. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Sweden Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Sweden Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Sweden. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Switzerland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Switzerland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Switzerland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Denmark Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Denmark Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Denmark. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Finland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Finland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Finland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Norway Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Norway Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Norway. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

China Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The China Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for China. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

India Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The India Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for India. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Japan Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Japan Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Japan. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Korea Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Korea Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Korea. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Australia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Australia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Australia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Thailand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Thailand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Thailand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Malaysia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Malaysia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Malaysia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Singapore Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Singapore Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Singapore. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

New Zealand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The New Zealand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for New Zealand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Caribbean Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Caribbean Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Caribbean region. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Argentina Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Argentina Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Argentina. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Colombia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Colombia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Colombia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Chile Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Chile Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Chile. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Guatemala Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Guatemala Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Guatemala. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Dominican Republic Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Dominican Republic Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Dominican Republic. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Costa Rica Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Costa Rica Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Costa Rica. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Panama Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Panama Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Panama. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Mexico Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Mexico Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Mexico. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Brazil Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Brazil Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Brazil. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Turkey Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Turkey Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Turkey. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Russia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Russia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Russia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Africa Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Africa Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Africa. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.
Schedule Meeting
Request Info
close
Video Transcription
close

Joe Mullings  0:08  
Well, thanks for joining me here at LSI 2022. I'm excited for this panel representing leadership in the med tech health tech industry. So I really appreciate all you joining us here. And I want to just jump right into it. We were having some great conversations beforehand. And as leaders in med tech right now, publicly traded company rapidly growing company soon to see if it goes public or not never know. That's me saying that not you. And from the investment community as well. How have you, Leslie, start with you? How have you started thinking about leading since January 2020? What are the dynamics that you're really plugged into that? Maybe were not on your radar screen before?

Leslie Trigg  0:52  
Pretty much everything. Maybe the easier question to answer is what's the same, because that would be one word, which is nothing. But I think more specifically, let's start with the beginning of the journey, which is recruiting. I never in my wildest dreams, I don't know about you guys thought I would ever hire anybody without meeting them in person. So we hired I want to say about 275 people last year, mostly, I would say almost entirely over zoom. So we've had to completely rethink the candidate expect from the candidates point of view, what is the candidate experience like? That's one, two, for sure. I would say for us the the hybridization, and then the geographical spread, I am very old fashioned. I really thought everybody was going to be hired from the Bay Area, work in the Bay Area together and be in an office together every single day. Now, out of that 650 employees, we only now have 100 in the Bay Area. So it has been a an explosion of talent across the country and also for us in Mexico. But that's led to a rethinking of how do you build culture, amplify culture, and make people feel bolted in versus just kind of bolted on? So those are just a couple of examples off the top of our head

Joe Mullings  2:04  
Curious, how do you build culture in a two dimensional zoom fatigue world? Right, because culture sort of historically, has been influenced by in person. So, Nadine, what have you changed? What have you noticed, with the explosive growth approximately? And then how do you maintain culture across?

Nadine Hachach-Haram  2:26  
I mean, I think you know, I would echo everything you said, I mean, it's it was definitely a surreal experience having to do that and triple or quadruple your team, you're trying to even think about how you're identifying the candidates, how you're wrapping around that kind of support infrastructure around them in a in a, in a world that's no longer in person, but at the same time, trying to identify the culture and the values. And so trying to really sync those up together. And, you know, we're in a little bit fortunate position in that the real draw of the talent that we bring in. And you need to look at the positives, you know, one of the great things about being able to be hybrid, you're bringing together lots of different cultures to influence a unit, a unifying culture of a company. So we've really been thinking a lot about that. But sometimes it's the, this the sort of straightforward things that you can do as well that just remind people and keep people hooked in and I like the bolt in versus bolt on comments. So you know, we are a company that's really working hard to try and connect and collaborate to enable the delivery of surgical care for patients and, and improve the quality and save lives for them. And so trying to really wrap around our values, and what we do around that culture was really important. So we started to introduce things like, you know, a monthly or weekly zoom, stand up, and then on that stand up, every week, someone will be sharing a mission and vision story, the why why are we doing what we do? How do we do it, even though they may not see anyone in the company for, you know, months at a time. But, you know, I definitely want to caveat that with it's not straightforward. I think anyone who says it's straightforward, you know, I'd like to know what their playbook is. It's, it's not but you know, we try to work really hard and invest in that space. And, you know, make sure that we're listening, that this is not static, this is dynamic, that we need to continue to change and evolve this and, you know, and we're learning as as as the whole world, this is not something that we've ever seen before. So I think it's just that humility and approaching and as well as really important.

Joe Mullings  4:16  
Amy, yourself and your role, especially.

Amy Belt Raimundo  4:18  
Yeah, it's interesting when COVID hit, we didn't think we didn't know what to do. We've never done an investment having never met a management team. And we thought, Oh, we're just gonna shut this whole thing down. And we are not going to make investments. And then it went on and on and on. And actually the last investment made, we had met the CEO the week before COVID, shut down. And so we made that investment, but then we were like, do we do any more? And it turns out, yeah, you can do investing. And you can fundraise. You can fundraise and in some ways you can get I mean, I completely agree with Leslie and Nadine's points that the challenges are as I come, I met I'm a three dimensional person person. But there are also new opportunities that I think there's an opportunity to exploit I mean, fundraising, you can get a lot more places a lot more efficiently. That way. Now, it's very difficult to build relationships. And so there's a, there's a trade off there. The other thing is, it's also easier to incorporate people from different locations, because we had, you know, people that were working remotely, that really struggled to get incorporated, that actually zoom is, you know, the great equalizer. It's like little Brady Bunch boxes, and everybody can be heard, everyone can hear everyone else. And so in some ways, that was sort of a positive because we could more easily incorporate those people. But the culture piece and building relationships building trust, we were sort of executing on trust that was already built. And that's that is possible. We, I think the humility comment is just right, like, we don't have answers, we have experiments, and see what will work what drives different ways of filling in the gaps that remote doesn't? Or what is the right mix of in person? And how do you do it? How do you organize in person because you can't be casual about it anymore? Because it's just not automatic? And so you have to be thoughtful when is in person key in versus when do we need to, you know, just get the gears going and work remotely? Because we have to.

Joe Mullings  6:30  
So do what are your concerns about if you've already established trust, and you've already established a career trajectory? And let's say that establishment is eight or nine years into your career, because the first five you should be noodling around with everything to figure out where you're going to go. Do you do you worry about the mentoring component, the in person mentoring component, and how that will be affected while we expand our reach on who we can add to our team? But if they're, two timezones away, and they're two years into their career, where do they get that mentoring component? So Nadine wants to start that,

Nadine Hachach-Haram  7:07  
I think it's a it's a super important comment, I think the reality is, is we've had to adapt to come up with new ways to do that, because you can't just not do it. It's so important. I mean, particularly with people that are a few years out and are, you know, this is like their second job or third job, and they're really excited about learning from who they may be reporting to, and spending that time. And so you have to be really intentional about, you know, setting time aside protecting time for that. And it may be in virtual, maybe some face to face, and we do more of a hybrid at the moment. But that's important. Also building the, you can't assume the trust is, you know, there's an assumption, especially if you've grown in, as you described in rescrub, you grew pretty quickly, there's a whole new people group of people that joined only virtually to start with. And so there it's, it's short sighted to assume trust in that period of time, you really want to build the rapport and the relationship. So we've been really thinking, how do we look at learning and development? How do we look at individual goal setting? How do we look at executive coaching? I mean, putting more robust executive coaching mechanisms for leadership in this new environment? How do they connect with their teams, and, you know, management, training, all these things that, you know, we'd assume people with experience would just get on with it, we had to we realize, we take a step back and, and really worked through that again. So we've really been trying to put mechanisms in place around that. And, you know, I think, personally, I mean, one of the, I think there's a lot of opportunity in the virtual I agree, it's a it's a real democratizer for sure. And it's been really nice to pull in talent from all over the world that historically might have been more challenging. I think as you grow that quickly, as well, on a personal level, the things that I often think about is, you know, I what I used to love when we were the 30, 40 group peoples, you know, I could spend time with everyone, you could really spend time so now it's if you're all in person, yes, there's the watercooler moment, you can still do that. With with the online, it's got to be really scheduled and, you know, intentional. So I've been really thinking through how do I how do we come up with new mechanisms and evolve our mechanisms that are more adaptable to the current to the current world, but it is a it is a really important comment about mentorship, and it's something I love doing and I'm sure a lot of my team leads do and we're constantly trying to evolve that. So yeah, we I think we've made some strides. But if any, anyone else has some good tips, you know, please pass them on

Joe Mullings  9:16  
Leslie, in your role. So you know, if I'm not mistaken, it was September 20, was it 2020 or 2021? You rang the bell and NASDAQ virtually?

Leslie Trigg  9:26  
Well, yeah, I didn't ring any Bell, right one. The most I was ever going to do is push the button. There was never going to be a bell involved, because we did go public on NASDAQ, but it was September 2020. So about six months after we had all retreated to our homes.

Joe Mullings  9:40  
So on the mentoring side, you're a leader and you've built a lot of your team over the last couple of years virtually. Yeah. So how do you give guidance and what do you tell the two three year person who's just joined your organization? Here's how we're going to help you grow, even if it's on a 2d screen.

Leslie Trigg  9:58  
Well, I think I think the thing that worries me the most is when I reflect on my first five or 10 years is the the opportunity is missed for observation. And so much of learning in my experience is through osmosis. And the osmosis occurs when you're observing, and it's hard to observe over zoom. There's so much subtlety to body language and watching I remember Amy and I are both at Guidant and I remember watching Ginger Graham. I watched not in a weird freaky way. Like I was obsessed with you, but still am. But I just I watched her a lot. I watched what she wore, I watch how quickly she walked the hallways, I watched how she interacted with assemblers all the way up to her executives, I watched her she handled tough questions. And, and so there's a lot of moments where you you can observe how do I interject? Or when can I interrupt or watching just sort of almost the interplay, you know, between people. So that's my biggest worry is that a lot of that is getting missed. On zoom, it is hard to interrupt. And it's it's hard to actually challenge somebody as much on on Zoom. So one of the things that we're trying to do is really turn our office into a what we'll call like purposeful collaboration. We're not going down the path that you have to be there three days a week, and it's got to be Monday, Wednesday, Friday. I think that's far too prescriptive. Because what if Monday, Wednesday, Friday isn't the right day. But what we are moving to is a real urge and encouragement toward we're doing in person meetings we're doing on on site meetings, one of our leaders, our Chief Commercial Officer started something called orchard week we have we live on orchard drive. And so he flies and yes, you have to invest in this. But he flies all the members of the commercial team, and they spend the week at Orchard and that's the right week. That's the week you all you want to be there. Because there's a lot of purposeful collaboration going on. So we're probably moving more toward intentional on site, rather than a routine kind of prescriptive approach. Whether it's right or wrong. I don't know. Because it's an experiment to your point. And I love that like there is no right or wrong. There's just taking a step forward learning and then iterating from there.

Joe Mullings  12:02  
Yeah. And do you think that we're trying to increase the efficiency of something that maybe shouldn't even exist right now. So meaning that the odds that in February of 2020, when we were all at JPMorgan, we remember that week or two afterwards, and you and I were were used to SDTS. Our response thereafter? Has the workplace structure changed a lot since our initial response? But what's the odds of that initial response being the correct one? So Amy, what if if you could fast forward a couple areas? Where do you see yourself spending time and giving guidance to the people that work with you on building leadership for the future?

Amy Belt Raimundo  12:40  
Yeah, it's interesting. I mean, you know, one thing, and we talked a little bit before, at med tech women, we stood up sort of a new net new mentorship program, that really was sort of harder to execute on in the non virtual world, because there's an efficiency associated with being able to get people to match in that world, because there's no travel time, there's no having to be in the same place. And so there's sort of net new opportunities to be able to sort of develop that class of folks. And I think that's actually, you know, I think what I would recommend for people coming up and then for, you know, leaders to to adopt, is there a way to have that sort of efficiently targeted mentoring program that you can sort of do via zoom? Because I think it does actually expand the number of lives you can touch with a smaller amount of time, and sort of there's an interesting sort of efficiency play associated with that. What I don't know, and I would love, you know, yeah. Any ideas about is that issue less that you raised sort of that first couple years, first five years, I mean, I remember being in my peer group, and sort of being nights and weekends and all hanging out together, because we are trying to learn from each other. And like, what are you doing? What's that and asking the dumb questions that everybody you know, everybody thinks they're dumb, and they're actually really functional? Like, how do you recreate that experience when people are working in their own home and zoom? It's hard to you know, that casual or that casual hanging out being able to flag a question. You know, I don't know if slack can mimic that.

Joe Mullings  14:25  
As a leader on that Zoom platform. So I know I'm, I'm in I've been caught it. Are you getting zoom fatigue? Where it's every meeting? I know when my meetings were face to face starting at 7am in the morning and work on to five at night. There's a different cognitive dissonance on Zoom versus in person. So personally, how do you manage yourself on that from a health, mental health and giving your teammates the best you can give them on Zoom? Are you doing anything different? Are you shutting off your camera or something? times I mean, this, I'm getting down to the micro here. But I'm curious as leaders, what you're doing to make sure you put the oxygen on yourself first.

Leslie Trigg  15:08  
Do you want to go first? I know. I, you know, I would say that again, maybe I'm old fashioned, I would never turn my camera off. Never ever, ever. It's just not about me, I when I'm in that environment, it goes to like, how do we form connectivity? And how do we form culture, we have very purposely established a culture of we're on camera all the time, unless you're eating or doing something embarrassing, or, you know, whatever exceptions to the rule, but I feel very, very strongly about on camera all the time, and I'm gonna set that example, it's just easier for me to be be more expressive, and try to capture a tiny bit of the in person interaction, if they can at least see me using my hand and I probably have elevated my hands a little bit closer to my face, and little adjustments like that. But, but really being able to kind of look somebody in the eye virtually, versus this black screen, I think the black screen is deadly, like I would absolutely never do it and never want any of our team members to operate that way.

Amy Belt Raimundo  16:04  
It's funny, I have that same reaction, like I think I'm a very visual person. But like, if you compare zoom to in person, Zoom is not as good as in person. But Zoom is far better than black screen for me. And so I really feel like there is, you know, there's an opportunity now, Zoom fatigue is real. And so, you know, sometimes I will switch over to a phone call where I'm walking around the neighborhood, in order to sort of break that, then we're but both people know, they're on a phone call. And you know, that's, you know, it just a way to, you know, but it's not as valuable from a from a team or expressive perspective, but it does give you sort of enough of a break, to sort of say, like, Oh, I am walking around, because I think the first I don't know, the first few months, I was like, all zoom all the time. And I was just, you know, I would just lie down on my couch after the day was done, because I just couldn't take it. And so part of it is just almost like, you know, physical training, is it like, can you need to be able to sustain it? So like, what do you pop in, but I think that's part of the experimentation is like, you know, like, what sort of things do you need to do to be able to sustain this new culture as it evolves, I think your point is well taken is, it continues to evolve, it is not done. And so we're gonna continue to figure that out. But the physical aspect of it is real. I have one, I have one trick. I stare at myself sometimes while I'm talking. Yeah, because there's something easier about not getting distracted by myself over in the corner. And so I like if I've got to, like really just kind of calm it all down, I can just start to see myself talking. Now some people do the absolute opposite, which they turn their screen off. So they're not staring at themselves, but staring at myself, for some reason, actually, just, it's, you know, it just means it's like you're talking to yourself in the mirror. So silly. Yeah.

Nadine Hachach-Haram  18:01  
I mean, I think, you know, a lot of the comments that I would agree with, I mean, we're early on, we were just back to back to back to back. And that was just, that was really hard. And so it's just being a bit more structured about gaps. And you know, you don't have to do calls from seven to seven, you know, you can take breaks, I do some walking calls as well. But I let people know that I'm off camera is going to be a phone call. And just making sure I mean, it's little things like I might start a day, you know, 30-40 minutes later and take an hour walk from home to the office, because I just feel like I need the fresh air, you need to get a bit of the stimulation of the environment before you just get into a desk and sort of sit at the desk. But I would love to not challenge but sort of give two other perspectives, perhaps to the sort of the zoo work site. I know. It's hard. And it's an I love the experiment analogy. And we're learning through it. And I do like the human contact as well. But I feel like the disruption we're seeing in the workplace is a disruption that Proximie was trying to make in the or right so 2014 I said, Why do i Why do I have to travel to X OR to see how a surgeon does something couldn't I just virtually scrub in. And that kind of conceptually, for surgeons that are very traditional, you know, as you said, we you know, we like the way we do things we always do the same way. You can imagine that behavior change and that culture change needed time. Now we're seeing the work from home, which is coming after but you know, I was talking about virtual operating rooms and connected operating rooms back in 2014. And now, you know, it's now it's becoming a reality, you know, we're seeing this becoming spread across all countries. Strategics using it to scale their companies, doctors using it to connect and feel mentorship, and taking that mentorship to the next level. You know, if you're stuck in a difficult case, and you can just ring in someone for 10 minutes to say, yep, you know, I would have done the same thing. You know, keep going that that extra level of mentorship. I think we can be creative about taking the you know, leveraging this new world and trying to think differently about how we do things. And the other point I would say is about you know, I know it's hard for the connection and the other but I think we've also opened up opportunities for people that found it hard to get to offices and found it hard to get to work, and we're stuck for two hours in traffic, and we're missing their kids dinnertime and in all those different things that were obstacles, I know as a kind of working mom of three, though, that was really difficult trying to manage all those things. And so now, the fact that I don't have to travel for two days to go to one meeting in person, I could actually just dial in, but I can be home for my kids homework and help them is something I think we also should consider as a plus to this new world. And maybe there's better ways to get a better work life balance out of it, too. It's not all easy. And it's not all straightforward. But I'm trying to see what are the also the positive things we can look at this come out of this,

Joe Mullings  20:39  
 I want to jump into an industry conversations going on quite aggressively right now in the changing centers of care, within outset, hold dialysis as a focus factor, right? Proximie changing standards of care whether it's ASC, whether it's a clinicians office, and obviously the OR. And as you look at opportunities, you have to look at where's this convergence going on? And how is it going to impact? So, like, your thoughts and starting out with that. One is what are your thoughts about the changing centers of care? And what are you keeping your eyes on over the next five years in that area?

Amy Belt Raimundo  21:20  
Yeah, I mean, I would say that it's a really exciting time that connectivity actually enables and so it allows a access, and a democratization that, you know, I think is, is in the ability to leverage technology leverage, really high level clinical expertise, much more broadly. And so I think that's exciting. Now, to do that, you have to set up a whole nother new systems and platforms. And so I think we take for granted sort of the traditional sort of hospital model, where you know, things have been dialed in, it was very efficient, from a sort of, you know, the hospital's perspective to have people there. Now, you're doing much more inside out all the way to the home. And so what do you need to build in from a logistics perspective, from a, you know, staffing perspective, responsiveness perspective? You know, what technology do you have to enable in those environments? That's different than pulling it all internal, and make it really super efficient, but not, you know, efficient for sort of the hospital, but not efficient for the patient for everyone else. And so I think that's that, you know, what we're looking for is yeah, what are those platforms? What are those technologies that really enable the ability to bring care closer to the patient, create more access, but it but it is, like, it's just a tremendous logistical service challenge that is being built right now. And so, you know, we're excited for really strong leaders that are doing that build and create those teams, the technologies, but I don't think it's, you know, point solutions, it's going to be either, you know, the platform that then acquires the point solutions, or the technology that then, you know, wraps around this service around

Joe Mullings  23:16  
You are saying there, that you're thinking that there might be platforms built for the distribution, the service, the ongoing compliance, and then organizations will then start buying business models that fit into that platform.

Amy Belt Raimundo  23:30  
Yeah, I would say that there are going to be technology, I mean, just think about medical technology sell into the hospital or the outpatient setting. And everything's our you know, all the contracting is already there, all the, you know, everything is already there, and then suddenly break that model. And so you're gonna need both the people that have figured out the logistics of that, and that may be bigger companies that may be technology solutions. And then what are the big enabling technologies that make that possible? Because again, you don't have the benefit, just like we were talking about the future of work, you don't have the benefit of someone right there that you can tap on the shoulder and say, Hey, can you help me, you have to, you have to, you know, you have to already set that system up. And so I see that as and I don't know what the business model is going to turn out to be. But it's going to be some combination of technology and service that really enables the ability to turn some of these things inside out.

Joe Mullings  24:31  
Leslie, from your position, right? You, you disrupted tremendously the dialysis market with bringing outsets platform into the home. Do you see that creating a pathway for other technologies, especially in the chronic care side of our business?

Leslie Trigg  24:47  
Well, I'd like to think so we're a long way away from that. I mean, we're just getting just getting started. I will say that one of the things I've learned just touching on what Amy just said is I would say I used to think that the device was the center point of the patient experience. And I would say that the device is probably 10% of the patient experience. And that's really forced us then to, frankly, unfortunately, from an investment time resource perspective, go and build a bunch of new stuff. The what, what really informs the patient experience and keeping people at home, that that's something we're talking a lot about getting people home, but at least in in our world, and for any chronic condition, the whole idea is to keep people at home, it's all about retention, because you really haven't done very much good in the world if somebody goes home, and they're back in two or three months later. So keeping people at home is really the people part of it. So for us, my big realization was it's kind of the to draw on Bill Clinton, it's sort of it's the people stupid, which is probably an old reference that nobody except for me remembers, maybe you, Joe, but it's the it's the people stupid and so are yes, the device has to perform it, it has to work well, in a home environment. That's no small feat where you have like kids, cats, Cokes, you know, carpets. But But beyond that, you have to be better than than the device and really provide the people ecosystem. That's, I think, for all of us as consumers, ends up being kind of 99% of your experience with a product.

Joe Mullings  26:12  
And so I hear there that convergence medtech always put the patient first and its profitability like and they need to because right, we deserve to make a good profit. So we continue to develop products, but we've never really been known as a consumer centric market. And then so now with all these open architectures and products coming out that service that 18% of our GDP, that maybe isn't a 510 K or PMA, but as a workflow or the patient experience, right, that's influencing. And so that brings me to Proximie right. You don't have an FDA oversight yet. Yet, you're impacting millions of patients. And it's about an experience on Proximie, not necessarily a diagnostic or a solution, per se, on the device side.

Nadine Hachach-Haram  26:58  
It's really been, I would I would echo with the points made earlier, I mean, I'm very excited about this decentralization as a practicing doctor and someone who was on the frontline, you know, even during COVID, it's not like the problem just became a problem during COVID. It's just it put a massive magnifying glass on what the challenge is this, these more antiquated models of care that are very bricks and mortar very specific to, to to that actually silo and don't give access to everyone, you know, people having to travel miles to get care. I mean, dialysis is a great example. I mean, we saw that in COVID, it was really difficult to get patients to dialysis that they needed. And so that is something that that is essential to really just take a step back and not try to keep duct taping the current model. But really say, we're going to build a new platform, a new system, a new behavior, change a new culture around the delivery of care. And I would completely echo the point that this can't be just a bunch of point solutions, because it's really difficult. If you're trying to do change management behavior, change whatever word you want to use, for every single one of those point solutions, it's, it's highly unlikely that it's going to succeed. But if you come across and say, I'm going to be the, the infrastructure, I'm going to be the workflow manager, I'm going to be the connector, the aggregator, the middleware, whatever you want to call it, that pulls the, you know, people systems strategics together, and then collectively unlocks value for all the different stakeholders, like you said, it's, it's not just about the patient or the doctor, it's, it's everything around it as well. It's the relatives, it's the system, it's the nurses, the healthcare workers, the payers, the providers. All of that is complicated. So you can if you can find a way to break through and disrupt that, I think you're well on your way, then to, to become at least the person that crowdsource of that brings it all together. And we have to be brave enough to shift it's really hard. I know, and I know is kind of working in a hospital how hard it is, you know, we still want to stick to our traditional EMRs and our traditional kind of in person clinics and blood testing facilities. And but we have to be brave. And we have to think that this inflection of supply and demand and the the investment and care has to be different. And we have to do that because people deserve it. patients deserve it, their relatives deserve it. So, you know, I get very excited when I see companies like yours that have really tried to break through but a thought holistically around. It's not just about building the box or the device. It's everything around it. And at Proximie we think about it the same way. It's not just about connecting a doctor to another. It's like what how can we continue to extend the value chain, pre op and post op and we have a long way to go still. I mean, we're still working through that. But we're we've already started to build the architecture that enables pre op and post op apps to plug in. So we don't have to build everything. There's great points there's not that need a home that needs to be part of a bigger mission. And we want to sort of be that platform that enables you to do that

Joe Mullings  29:41  
That is super exciting. Medtech is becoming an open architecture where it used to be really a one way street a lot of times because we were so wrapped onto the device, justifiably so. So that's exciting. Alright, last question for each of you. You're you're all leaders, in your in your companies in our industry. How How do you manage your own self learning? How important is ongoing learning to personal professional growth? And how do you find time with it? Where do you spend your time on that? So Amy?

Amy Belt Raimundo  30:12  
Yeah, it's a, I have to say that one of the reasons I was attracted to venture was the constant learning. So and I did actually add Gaiden, we did the, the StrengthsFinder. Yeah. And learner was actually one of my five. So it's super important. You know, for me, you know, I get it naturally through some of the companies I get involved in, because you're constantly learning. The others, I recently took a public board role. And so the ability to, you know, take my board experience, but into the public realm, you know, really was a way to push and challenge. And then I also decided to, you know, launch a venture fund in the middle of this. So again, it's sort of the, like, keep pushing my own boundaries, in terms of not being necessarily, you know, saying, safe, in what I know, but can I add, like, take the experience I had, but then add a component by taking something new on, and that, for me, has always kept me energized, always kept me learning. And I think, you know, that's what I've done. I think my whole career, and it never stops for me.

Joe Mullings  31:21  
And comfortable enough with being that old adage, we're always the fool before we're the master. Yeah,

Amy Belt Raimundo  31:27  
Yeah, you have to be comfortable with being uncomfortable. Like, it just is, that is how you grow. And the better you get at that, passing through that, the more and faster you'll grow. And then the more interesting the world becomes, I would say that, you know, when I think about careers, I thought it was going to be easier. But less interesting than it turned out to be is harder and more interesting. Every day

Joe Mullings  31:53  
Maybe because you're really stretching for your each bogie, you go after meeting your thoughts on that. So how do you keep your learning up? Other than survival learning? I know, we're all guilty. But lauric learning, like, I need to learn this, that's the way to maybe outside of business.

Nadine Hachach-Haram  32:10  
Yeah. I mean, it's, uh, you know, I also scored high as well as a thirst for learning type of, you know, and humility, I think so, you know, I keep saying it, but it is really important, recognizing that, you know, it's okay not to know everything. But, you know, and I take many approaches. One is I really try to, you know, hire top top kind of people around me, because I think I can learn a lot from them, too. And it's really reciprocal, I think this idea that I'm the CEO, so I should know more than everyone else is just, you know, is outdated. So I really thrive by learning from people around me sitting in on their meetings and trying to see how they communicate with their teams, how they communicate with customers, that's kind of something I enjoy. Equally, you know, I think it's really great to continue to invest in executive coaching that pushes you, you know, I'm constantly, you know, listening to podcasts, reading books, trying to see, you know, how are other people thinking about these problems? And, and how are they addressing them, it doesn't necessarily mean that they know all the answers, but just thinking through it. And then finally, I've, I've invested time in being part of a CEO network, and we come together once a month, it's a great, you know, four hours, where, you know, every month an executive has to share a challenge that they have in their business. And it doesn't almost matter what your business is, it could be autonomous cars, it could be healthcare, it could be whatever it is, it could be retail, but you there is attendant, there tends to be a pattern of sort of challenges that you as a leader have. And so listening in a very safe space, could be board issues, fundraising, really makes you think about I'm not alone. Others may have some challenges, or, actually, I solved this two years ago, let me see if I can help this individual with some suggestions, is really a great way to continue to drive that forward. So it's that constant, of course, coming to meetings like this, where you can, you know, connect with great people like Amy and Leslie and others, I think is really helpful.

Leslie Trigg  33:49  
Well, I'm gonna fall down on the job. Those are both great answers. I would say that I have probably been highly self critical. I don't I haven't done structured learning. And I don't remember my strength thing was, but I do remember taking Myers Briggs and I showed up as an introvert and I was shocked. And I've taken another one, and I doubled down on the introvert thing. So maybe this is not surprising. Reflecting on this question, I read I do read a lot. However, I don't read business books. Then every time I listen to like the Google CEO, the new one I'm forgetting his name. I'm not reading the right things like they're not highbrow so to be perfectly honest, I read everything from like people, I am a religious people magazine reader. Proud to have never revealed this before. No, I'm kidding. People us trashy mags given to me. But I do because I like to actually stay current with with with culture. And I found that no kidding. I have used things that I've learned from People Magazine, in, in everyday life, everyday conversation. So it's everything from people to and then I read. I've gotten tipped off on a couple of of tech publications, the information, Strategery. which is more esoteric newsletter about tech. One of our one of our backers, one of our investors, has a WhatsApp group with CEOs across med tech tech, environment, whatever. That's been really a really cool source of learning. So I think what I learned is like, let it go. You're not supposed to be learning something and it doesn't mean you're not smart. If you're reading People Magazine, that's that's my pitch. But other than that, I would say I do I try to read a lot and I do a lot of observation. And maybe that is why I'm an introvert. I don't know,

Joe Mullings  35:32  
Maybe. Well, this has been fantastic. I appreciate each your time. I know you're super busy at this conference. And I know our audience will appreciate this session as well. Thank you so much. Thank you. That's great. I'm Joe Malines, from LSI 2020 to be well

back Back to all attendees close
Leslie Trigg

Leslie Trigg

CEO, Outset Medical

Leslie has served as our Chief Executive Officer since November 2014 and was elected Chair in 2022. She joined the Company from Warburg Pincus, a private equity firm, where she was an Executive in Residence from March 2012 to March 2014. Prior to that, she served in several roles at Lutonix (acquired by CR Bard), a medical device company, from January 2010 to February 2012, most recently as Executive Vice President, and as Chief Business Officer of AccessClosure (acquired by Cardinal Health), a medical device company, from September 2006 to June 2009. She also previously held positions with FoxHollow Technologies (acquired by ev3/Covidien), a manufacturer of devices to treat peripheral artery disease, Cytyc, a diagnostic and medical device company, Pro-Duct Health (acquired by Cytyc), a medical device company, and Guidant, a cardiovascular medical device company. Ms. Trigg serves on the board of directors of Adaptive Biotechnologies (NASDAQ: ADPT) and on the board of directors of the Medical Device Manufacturers Association. Ms. Trigg holds a B.S. degree from Northwestern University and an M.B.A. from The Haas School of Business, UC Berkeley.

  • linkedin
  • Website website
back Back to all attendees close

Leslie Trigg

CEO, Outset Medical

Leslie has served as our Chief Executive Officer since November 2014 and was elected Chair in 2022. She joined the Company from Warburg Pincus, a private equity firm, where she was an Executive in Residence from March 2012 to March 2014. Prior to that, she served in several roles at Lutonix (acquired by CR Bard), a medical device company, from January 2010 to February 2012, most recently as Executive Vice President, and as Chief Business Officer of AccessClosure (acquired by Cardinal Health), a medical device company, from September 2006 to June 2009. She also previously held positions with FoxHollow Technologies (acquired by ev3/Covidien), a manufacturer of devices to treat peripheral artery disease, Cytyc, a diagnostic and medical device company, Pro-Duct Health (acquired by Cytyc), a medical device company, and Guidant, a cardiovascular medical device company. Ms. Trigg serves on the board of directors of Adaptive Biotechnologies (NASDAQ: ADPT) and on the board of directors of the Medical Device Manufacturers Association. Ms. Trigg holds a B.S. degree from Northwestern University and an M.B.A. from The Haas School of Business, UC Berkeley.

  • linkedin
  • Website website
Leslie Trigg
back Back to all attendees close
Nadine Hachach-Haram

Nadine Hachach-Haram

Founder & CEO, Proximie

Dr. Nadine Hachach-Haram is a surgeon, lecturer and clinical entrepreneur. She drew on her passion for innovation, education and global surgery to co-found Proximie, an augmented reality platform that allows doctors to virtually transport themselves into any operating room, anywhere in the world, to visually and practically interact in an operation from start to finish. From marking up a patient to providing real-time virtual presence in assisting and instructing on an operation, Proximie aims to provide safe, accessible and cost-effective surgery to every patient around the world. Dubbed the "future of surgery" by CNN, Proximie has gone from strength to strength and won multiple awards as well as being the main focus of the Foreign Press Association Science Story of the Year. It aims to revolutionize the delivery and education of healthcare by reducing the cost of that delivery while providing improved quality to the end patient, ensuring that every patient gets the best care, the first time, every time.

  • linkedin
  • Website website
back Back to all attendees close

Nadine Hachach-Haram

Founder & CEO, Proximie

Dr. Nadine Hachach-Haram is a surgeon, lecturer and clinical entrepreneur. She drew on her passion for innovation, education and global surgery to co-found Proximie, an augmented reality platform that allows doctors to virtually transport themselves into any operating room, anywhere in the world, to visually and practically interact in an operation from start to finish. From marking up a patient to providing real-time virtual presence in assisting and instructing on an operation, Proximie aims to provide safe, accessible and cost-effective surgery to every patient around the world. Dubbed the "future of surgery" by CNN, Proximie has gone from strength to strength and won multiple awards as well as being the main focus of the Foreign Press Association Science Story of the Year. It aims to revolutionize the delivery and education of healthcare by reducing the cost of that delivery while providing improved quality to the end patient, ensuring that every patient gets the best care, the first time, every time.

  • linkedin
  • Website website
Nadine Hachach-Haram
back Back to all attendees close
Amy Belt Raimundo

Amy Belt Raimundo

Co-Founder & Managing Partner, Convey Capital

Previously, Amy led Kaiser Permanente Ventures as a managing director in 2016. Amy brings over 20 years of experience in healthcare investing, start-up and corporate operations and hospital system consulting.

Amy has spent a dozen years in venture capital including Covidien Ventures and Advanced Technology Ventures (ATV). Immediately prior to joining KPV, Amy was the Chief Business Officer of digital health start-up Evidation Health. Amy has spent close to a decade in venture capital at Covidien Ventures and Advanced Technology Ventures (ATV). Prior to KP Ventures, she led investments in Medina Medical (acquired by Medtronic) and Nevro Corporation (NYSE: NVRO) among others. Earlier in her career, Amy held operating roles at Guidant Corporation and began her career as a management consultant for hospitals at APM/CSC Healthcare.

Amy is a Kauffman Venture Fellow as well as founder and president of MedtechWomen. She holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.

  • linkedin
back Back to all attendees close

Amy Belt Raimundo

Co-Founder & Managing Partner, Convey Capital

Previously, Amy led Kaiser Permanente Ventures as a managing director in 2016. Amy brings over 20 years of experience in healthcare investing, start-up and corporate operations and hospital system consulting.

Amy has spent a dozen years in venture capital including Covidien Ventures and Advanced Technology Ventures (ATV). Immediately prior to joining KPV, Amy was the Chief Business Officer of digital health start-up Evidation Health. Amy has spent close to a decade in venture capital at Covidien Ventures and Advanced Technology Ventures (ATV). Prior to KP Ventures, she led investments in Medina Medical (acquired by Medtronic) and Nevro Corporation (NYSE: NVRO) among others. Earlier in her career, Amy held operating roles at Guidant Corporation and began her career as a management consultant for hospitals at APM/CSC Healthcare.

Amy is a Kauffman Venture Fellow as well as founder and president of MedtechWomen. She holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.

  • linkedin
Amy Belt Raimundo
back Back to all attendees close
Joe Mullings

Joe Mullings

Chairman & CEO, The Mullings Group Companies

Joe Mullings has been building companies and careers since 1989. He is the Founder, Chairman and CEO of The Mullings Group, the world’s leading search firm in the medical device industry. The firm is responsible for more than 7,000 successful searches, representing more than 600 companies in the medical device industry.

His clients are multi-billion-dollar companies, as well as emerging startup companies that are bringing to market emerging technologies like surgical robotics, tele-robotics, artificial intelligence and deep learning. He is also President & CEO of Dragonfly Stories, which is the production company behind the video docuseries “TrueFuture” of which he is the host. He is also the founder of TMGPulse, a MedTech news and opinion website. He holds an engineering degree from The University of Dayton, Ohio.

  • linkedin
  • Website website
back Back to all attendees close

Joe Mullings

Chairman & CEO, The Mullings Group Companies

Joe Mullings has been building companies and careers since 1989. He is the Founder, Chairman and CEO of The Mullings Group, the world’s leading search firm in the medical device industry. The firm is responsible for more than 7,000 successful searches, representing more than 600 companies in the medical device industry.

His clients are multi-billion-dollar companies, as well as emerging startup companies that are bringing to market emerging technologies like surgical robotics, tele-robotics, artificial intelligence and deep learning. He is also President & CEO of Dragonfly Stories, which is the production company behind the video docuseries “TrueFuture” of which he is the host. He is also the founder of TMGPulse, a MedTech news and opinion website. He holds an engineering degree from The University of Dayton, Ohio.

  • linkedin
  • Website website
Joe Mullings